Prior authorization is a request the prescribing office files with a pharmacy benefit manager before a drug will be paid for. It is assembled from the chart, not from a conversation. Two related requests are often confused with it, and picking the wrong one costs weeks. Approvals also expire, so the process repeats.
Three requests that people call by one name
Prior authorization asks whether a patient meets a plan’s written rules for a drug that is already on the plan’s list. A formulary exception asks the plan to cover a drug that is not on its list at all. A tier exception asks the plan to charge a lower cost share for a drug it already covers. They are answered by different rules, they carry different evidence expectations, and filing the wrong one produces a refusal that says nothing useful about the actual question.
Which one applies depends on how the plan treats the drug, and that is knowable before anything is submitted. The drug list shows whether the product appears, on what tier, and whether authorization is flagged. Ten minutes reading it saves a cycle of guessing. Federal program rules published by CMS describe this structure for Medicare drug plans, and commercial benefit managers run a broadly similar architecture with plan-specific content.
| Request type | The question it asks | Filed by | Typical trigger |
|---|---|---|---|
| Prior authorization | Does this patient meet the plan’s rules for a listed drug? | Prescribing office | Drug list flags authorization required |
| Formulary exception | Will the plan cover a drug it does not list? | Prescribing office, with a supporting statement | Drug absent from the list |
| Tier exception | Will the plan apply a lower cost share? | Prescribing office | Covered but at a high tier |
| Reauthorization | Should an existing approval continue? | Prescribing office | Approval nearing expiry |
The request is assembled from four sources
What reaches a reviewer is a compilation, and each part comes from somewhere different. The clinical record supplies dated measurements, diagnoses and visit notes. The laboratory system supplies results. The pharmacy claims history, which the benefit manager can often see on its own, supplies evidence of what has actually been filled and when. The patient supplies history that predates the current practice, including treatments tried elsewhere.
The fourth source is the weakest link, because a treatment tried three years ago at a different clinic exists only in the patient’s memory unless someone writes it down. Bringing dates, drug names and reasons for stopping to the visit converts recollection into chart content, and chart content is the only thing a reviewer can act on.
Why the pharmacy claims history matters more than expected
Benefit managers sit on top of a record of every prescription they have paid for. That record is used to check consistency between what a request asserts and what the data shows. A request describing a long history of a prior medication is easier to accept when fills for that medication appear in the file, and harder when they do not because the drug was paid for in cash or under a previous employer’s plan.
This is not an accusation of bad faith. It is a reason to state plainly when a prior trial happened outside the plan’s visibility, so a reviewer reads a gap as a data limitation rather than a contradiction.
What reviewers are and are not doing
A reviewer applies a written policy to a submitted file. They are not evaluating whether treatment is a good idea in general, and they are not weighing the persuasiveness of a letter. The policy names the facts that have to be present. If a fact is present in the file, the box is checked. If it is absent, the box is not checked, whatever the clinical reality.
Criteria content varies by plan and is revised on an annual cycle, sometimes more often, so nothing general should be assumed about what any particular plan requires. Asking for the specific policy document under which a request will be judged is a normal request and it is the only way to write to the actual target. The published prescribing information for the drug, available through DailyMed, is a separate reference and sets the approved indications rather than the plan’s rules.
Turnaround and the urgent track
Standard review runs on a defined clock, and an expedited track exists for situations where waiting would seriously jeopardize health. Federal timeframes for Medicare drug plans are published by CMS, and group health plans operate under their own federal notice and timing framework. Both distinguish standard from urgent, and both shorten the clock substantially for the urgent path.
Electronic submission moves faster than fax in practice, because it validates required fields at entry rather than after a reviewer opens an incomplete page. Offices that still fax should at minimum confirm receipt, since an unacknowledged fax is indistinguishable from a request that was never filed.
The gap between filing and dispensing
Even a request that will succeed produces a period with no medication. Discontinuation research on incretin therapy shows weight returning after treatment stops, so an interruption has a real cost rather than a neutral pause. Some people keep a self-pay course going while the paperwork moves. Supervised telehealth practices quote a flat monthly figure that covers the visit and the medication, and the provider behind it handles the prescribing and pharmacy arrangements directly, though compounded preparations of this kind have not been through FDA approval.
Reauthorization is a second review
Approvals are granted for a period, not permanently, and the renewal review is a genuine review. Plans commonly want evidence that treatment is working before continuing it, which means the measurements taken during the approval period become the evidence for the next one. A patient who never returns for a documented weight check has produced no data for the renewal file.
Renewals also land near plan year boundaries, when drug lists and criteria may have been rewritten. An approval granted under last year’s policy does not carry forward automatically into a policy that no longer exists in the same form.
Because a renewal can lapse and coverage can change between jobs, some patients track what the direct-pay market charges before they ever need it. LillyDirect sells the manufacturer’s vials at a set price, telehealth providers such as Ro, Hims and Hers, and Henry Meds post their own monthly rates, and HealthRX lists Zepbound pricing on its site. These are separate providers offering different products at different prices, so a quick comparison beats reaching for the first name in a search.
Questions readers ask
Can a patient file the request themselves?
Generally no for prior authorization, since the submission requires clinical documentation the prescriber holds. Members can usually request an exception or start an appeal in their own name, and can always request copies of the plan’s criteria. The clinical content still has to come from the prescribing office.
How long is an approval good for?
It varies by plan and by drug, and the duration is stated in the approval notice rather than being a fixed industry standard. The practical step is to read that date when the approval arrives and set a reminder well before it, because a renewal filed after expiry creates a pharmacy gap that could have been avoided.
Does a peer-to-peer conversation help?
Sometimes, because it lets the prescriber supply context that a form cannot hold. It works best when a specific criterion was cited and the prescriber can address that criterion directly. It does not change plan rules, so it has little effect where the underlying issue is a benefit exclusion rather than a clinical finding.
What happens if the dose increases later?
Quantity limits are usually written per dose strength, so moving up a step can push a prescription outside the approved parameters even while the approval remains active. Flagging the escalation schedule at the time of the original request avoids a second round of paperwork at exactly the point treatment is being intensified.
